What Does TB-500 Add to the Wolverine Peptide Stack
At 12 months, patients receiving exenatide had a mean improvement of 2.7 points, while the control group had a mean decline of 2.2 points, indicating a statistically significant difference of 4.9 points (95% CI, 0.3-9.4
Plain Language Summary Obesity is a growing public health issue that increases the risk of developing heart disease, type 2 diabetes, and osteoarthritis
Exenatide (Byetta) is initiated at 5 mcg twice daily, with a potential increase to 10 mcg twice daily after one month
In 2025, it was also approved to treat chronic kidney disease in patients with Type 2 diabetes
Their complementary mechanisms make them a valuable set of tools for research in regenerative medicine